Library — CHDR

Search

Filter

Spotlight Commentary: How to prove pharmacology of immunomodulatory drugs in a phase 1 trial?

Rissmann R, Szabadi E

British journal of clinical pharmacology, 2019 Jun; 85(7):1389-1390

View publication
The effect of repeated methotrexate injections on the quality of life of children with rheumatic diseases.

Jacobse J, Ten Voorde W, Rissmann R, Burggraaf J, Ten Cate R, Schrier L

European journal of pediatrics, 2019 Jan; 178(1):17-20

View publication
The ultraviolet B inflammation model: postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjects.

Siebenga PS, van Amerongen G, Klaassen ES, de Kam ML, Rissmann R, Groeneveld GJ

European journal of pain (London, England), 2018 Dec

View publication
Effects of two antihistamine drugs on actual driving performance.

Cohen AF, Posner J

British medical journal (Clinical research ed.), 2018 Dec; 288(6421):935

View publication
Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS.

Monnet E, Lapeyre G, Poelgeest EV, Jacqmin P, Graaf K, Reijers J, Moerland M, Burggraaf J, Min C

Clinical pharmacology and therapeutics, 2018 Dec; 101(2):200-208

View publication
Human immunodeficiency virus--associated non-Hodgkin's lymphoma presenting as an auricular perichondritis.

Levin RJ, Henick DH, Cohen AF

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2018 Dec; 112(3):493-5

View publication
Sample Aging Profoundly Reduces Monocyte Responses in Human Whole Blood Cultures.

Grievink HW, Moerland M

Journal of immunology research, 2018 Aug

View publication
MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216.

Reijers JAA, Kallend DG, Malone KE, Jukema JW, Wijngaard PLJ, Burggraaf J, Moerland M

Cardiovascular drugs and therapy, 2018 May; 31(4):381-389

View publication
Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens.

Ortiz Zacarías NV, Dijkmans AC, Burggraaf J, Mouton JW, Wilms EB, van Nieuwkoop C, Touw DJ, Kamerling IMC, Stevens J

Pharmacology research & perspectives, 2018 May

View publication

«
1
2
3
4
5
6
7
8
»